Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 -62.08M
March 31, 2026 -86.56M
December 31, 2025 -168.85M
September 30, 2025 -191.50M
June 30, 2025 -194.72M
March 31, 2025 -128.48M
December 31, 2024 -148.23M
September 30, 2024 -154.91M
June 30, 2024 -99.23M
March 31, 2024 -161.64M
December 31, 2023 -136.00M
September 30, 2023 -92.62M
June 30, 2023 -128.95M
March 31, 2023 -116.14M
December 31, 2022 -106.07M
September 30, 2022 -122.10M
June 30, 2022 15.10M
March 31, 2022 85.27M
December 31, 2021 89.00M
September 30, 2021 92.67M
June 30, 2021 -39.42M
March 31, 2021 -94.77M
December 31, 2020 -84.25M
September 30, 2020 -78.42M
June 30, 2020 -65.28M
Date Value
March 31, 2020 -58.57M
December 31, 2019 -52.95M
September 30, 2019 -60.27M
June 30, 2019 -84.51M
March 31, 2019 -14.86M
December 31, 2018 -29.06M
September 30, 2018 -47.23M
June 30, 2018 -36.93M
March 31, 2018 -132.14M
December 31, 2017 -140.71M
September 30, 2017 -138.20M
June 30, 2017 -154.11M
March 31, 2017 -145.41M
December 31, 2016 -130.46M
September 30, 2016 -113.37M
June 30, 2016 -91.55M
March 31, 2016 -73.65M
December 31, 2015 -63.01M
September 30, 2015 -54.91M
June 30, 2015 -50.62M
March 31, 2015 -33.75M
December 31, 2014 -1.138M
September 30, 2014 0.5954M
June 30, 2014 2.503M
March 31, 2014 -10.41M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Alkermes Plc 221.65M
Amarin Corp. Plc 15.55M
Agenus, Inc. -98.50M
Amgen, Inc. 10.18B
Anika Therapeutics, Inc. 0.562M